PDG17 COST-EFFECTIVENESS OF THE SECOND LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
May 1, 2019, 00:00
10.1016/j.jval.2019.04.696
https://www.valueinhealthjournal.com/article/S1098-3015(19)30888-5/fulltext
Title :
PDG17 COST-EFFECTIVENESS OF THE SECOND LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30888-5&doi=10.1016/j.jval.2019.04.696
First page :
Section Title :
Open access? :
No
Section Order :
10297